Labcorp Holdings Inc. ( NYSE: LH) Q1 2025 Earnings Conference Call April 29, 2025 9:00 AM ET Christin O’Donnell - Investor Relations Adam Schechter - Chairman & Chief Executive Officer Julia Wang - ...

Innovative treatments and devices, plus ongoing research conducted by aging experts, are providing us better insight into our ...

Good day, and thank you for standing by. Welcome to the Q1 2025 Laboratory Corporation of America Holdings Earnings ...

The need for more organ and tissue donors impacts thousands nationwide, including hundreds in Delaware. These are just a few Delaware stories.

“The reason there’s a difference here is because we have a chronic form of treatment for ... she did an initial blood test at a local LabCorp and found out that the two were a “zero mismatch.” ...

Laboratory operator Labcorp beat analysts' estimate for first-quarter profit on Tuesday, helped by robust demand for its ...

These additions include Labcorp Plasma Detect, a blood-based test for assessing recurrence risk in stage III colon cancer patients, and PGDx elio plasma focus Dx, the first FDA-authorized kitted ...

Bengaluru: Laboratory operator Labcorp beat analysts' estimate for first ... acquisitions and partnerships and further expand our test menu in four strategic areas, including oncology, women's ...

Results from Operations for first quarter 2025 versus first quarter last year:Revenue: $3.35 billion versus $3.18 billionDiluted EPS: $2.52 versus $2.69Adjusted EPS: $3.84 versus $3.68Reaffirmed ...